U.S. flag

An official website of the United States government

NM_031448.6(C19orf12):c.392A>C (p.Lys131Thr) AND not specified

Germline classification:
Benign (3 submissions)
Last evaluated:
May 31, 2018
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000116508.10

Allele description [Variation Report for NM_031448.6(C19orf12):c.392A>C (p.Lys131Thr)]

NM_031448.6(C19orf12):c.392A>C (p.Lys131Thr)

Gene:
C19orf12:chromosome 19 open reading frame 12 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q12
Genomic location:
Preferred name:
NM_031448.6(C19orf12):c.392A>C (p.Lys131Thr)
Other names:
NM_001256047.1(C19orf12):c.392A>C(p.Lys131Thr); NM_001282929.1(C19orf12):c.200A>C(p.Lys67Thr); NM_001282930.1(C19orf12):c.200A>C(p.Lys67Thr); NM_001282931.1(C19orf12):c.200A>C(p.Lys67Thr); NM_031448.4(C19orf12):c.392A>C(p.Lys131Thr); NM_001031726.3(C19orf12):c.425A>C(p.Lys142Thr)
HGVS:
  • NC_000019.10:g.29702746T>G
  • NG_031970.2:g.18044A>C
  • NM_001031726.4:c.392A>C
  • NM_001256046.3:c.*13A>C
  • NM_001256047.2:c.392A>C
  • NM_001282929.1:c.200A>C
  • NM_001282930.3:c.200A>C
  • NM_001282931.3:c.200A>C
  • NM_031448.6:c.392A>CMANE SELECT
  • NP_001026896.2:p.Lys142Thr
  • NP_001026896.3:p.Lys131Thr
  • NP_001242976.1:p.Lys131Thr
  • NP_001269858.1:p.Lys67Thr
  • NP_001269859.1:p.Lys67Thr
  • NP_001269860.1:p.Lys67Thr
  • NP_113636.2:p.Lys131Thr
  • NC_000019.9:g.30193653T>G
  • NM_001031726.2:c.425A>C
  • NM_001031726.3:c.425A>C
  • Q9NSK7:p.Lys142Thr
Protein change:
K131T
Links:
UniProtKB: Q9NSK7#VAR_066622; dbSNP: rs79915936
NCBI 1000 Genomes Browser:
rs79915936
Molecular consequence:
  • NM_001256046.3:c.*13A>C - 3 prime UTR variant - [Sequence Ontology: SO:0001624]
  • NM_001031726.4:c.392A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001256047.2:c.392A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282929.1:c.200A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282930.3:c.200A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001282931.3:c.200A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_031448.6:c.392A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000150456Genetic Services Laboratory, University of Chicago
no assertion criteria provided
Likely benigngermlineclinical testing

SCV000518672GeneDx
criteria provided, single submitter

(GeneDx Variant Classification (06012015))
Benign
(Feb 11, 2016)
germlineclinical testing

Citation Link,

SCV000803519SIB Swiss Institute of Bioinformatics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Benign
(May 31, 2018)
unknowncuration

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownunknownnot providednot providednot providednot providednot providedcuration
not providedgermlineyesnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee.

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Genetic Services Laboratory, University of Chicago, SCV000150456.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From GeneDx, SCV000518672.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot providednot providednot provided

From SIB Swiss Institute of Bioinformatics, SCV000803519.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedcuration PubMed (1)

Description

This variant is interpreted as a Benign - Stand Alone. The following ACMG Tag(s) were applied: BA1 => Allele frequency is >5% in Exome Sequencing Project and 1000 Genomes Project, or Exome Aggregation Consortium.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024